Latest Srinivas Nalamachu Stories
MALVERN, Pa., Aug. 19, 2014 /PRNewswire/ -- SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products for the treatment of pain, announced that it had formed a Scientific Advisory Board composed of four members: Dr. Jeff Gudin, Dr. Charles Argoff, Dr. Srinivas Nalamachu and Mr. Kip Vought. SCILEX Chief Executive Officer Anthony Mack said the expertise of this board would greatly assist in the development and...
- Good cheer; viands.
- To revel; to feast.